A spending bill that allocates $2.34 billion to Alzheimer’s research funding for fiscal year 2019 was signed into law by President Trump today. The bill passed the Senate last month by an 85–7 vote, and was approved by the House in its final form by a 361–61 vote on September 26. The 2019 AD budget tops last year’s spending on the disease by $425 million. The AD research funding is part of the $39.1 billion designated to the National Institutes of Health—a $2 billion raise over last year’s funding for the agency (for more, see Aug 2018 news).
No Available Further Reading